FDA - Search News

Listeria, FDA and frozen nutritional shakes

Map Shows States With Listeria Cases as FDA Recalls Nutritional Shake

A nationwide recall of frozen nutritional shakes has been issued after a listeria outbreak tied to the drinks resulted in multiple hospitalizations and deaths across the United States, according to the U.

CNN · 1d

Listeria outbreak linked with supplemental shakes now stands at 12 deaths, FDA says

Twelve deaths have been reported as part of an outbreak of Listeria monocytogenes infections linked to frozen supplemental shakes, the US Food and Drug Administration said Monday. At least 38 people in 21 states had been infected,

Reuters · 1d

US FDA, CDC investigating multi-state listeria outbreak

The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention said on Monday the agencies were investigating a multi-state outbreak of listeria infections linked to frozen supplemental shakes manufactured by Prairie Farms Dairy Inc.

Drug compounders sue FDA over semaglutide status

The Hill on MSN · 9h

Drug compounders sue over weight loss drugs’ removal from FDA shortage list

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug

Reuters · 1d

Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list

Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's weight-loss and diabetes treatments Wegovy and Ozempic from its shortage list,

The National Law Review · 12h

GLP-1 Drugs: FDA Removes Semaglutide from the Drug Shortage List

On February 21, 2025, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order determining that the semaglutide drug shortage has been resolved. The timing of this order was unexpected due to the ongoing litigation between FDA and the Outsourcing Facilities Association (OFA) involving tirzepatide,

Medtronic gets FDA approval for Brainsense device

Reuters · 1d

US FDA approves Medtronic's medical device for Parkinson's disease

The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.

MarketWatch · 1d

Medtronic Parkinson's Disease Brain Stimulation System Gets FDA Approval

Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease. The medical technology company said the regulator approved BrainSense Adaptive deep brain stimulation and BrainSense Electrode Identifier.

Axios Vitals on MSN · 20h

FDA OKs adaptive brain pacemaker for Parkinson's treatment

The Food and Drug Administration on Monday granted its first approval for a pacemaker-like device for the brain to ease symptoms of Parkinson's disease, which affects nearly 1 million people in the United States.

'This guy': Trump Jr.’s hunting buddy to be top food regulator at FDA

What we are seeing from this administration is literally an inversion of a merit-based system—a spoils system for cronies and ...

18hon MSN

Smokescreen: some vape firms pivot after FDA crackdown

Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...

1don MSN

FDA delays when a final rule on what foods can be labeled as ‘healthy’ goes into effect

The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will ...

STAT15h

Trump’s FDA navigates layoffs, exits, and a new hire

The Trump administration has started rehiring some of the FDA employees it fired last week, the latest chapter in a haphazard ...

1don MSN

FDA Moves to Rehire Medical Device Staffers Fired Only Days Earlier

The reversal is the latest example of President Donald Trump and billionaire Elon Musk's chaotic approach to cost-cutting, ...

Ex-FDA commissioner on implications of agency’s ‘unreasonable’ jobs cuts

Dr. Robert Califf, former FDA commissioner and instructor at Duke Department of Medicine, explains the negative implications ...

2don MSN

FDA Asks 300 Fired Scientists to Return

The FDA plans to rehire around 300 people in total, according to four sources with secondhand knowledge of the situation, ...

Targeted Oncology10h

FDA Grants Perioperative Pembrolizumab Priority Review in HNSCC

The FDA granted priority review to pembrolizumab for neoadjuvant and adjuvant use in head and neck squamous cell carcinoma, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Listeria, FDA and frozen nutritional shakes

Drug compounders sue FDA over semaglutide status

Medtronic gets FDA approval for Brainsense device

Related topics